Absence of donor CD40 protects renal allograft epithelium and preserves renal function

Transplant International

Volumn 26, Issue 5, 2013, Pages 535-544

  Kraus, Anna Katharina ^a,b   Cippá, Pietro Ernesto ^a,b   Gaspert, Ariana ^b   Chen, Jin ^a,b   Edenhofer, Ilka ^a   Wüthrich, Rudolph Peter ^a,b   Lindenmeyer, Maja ^a,b   Segerer, Stephan ^a,b   Fehr, Thomas ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CD40; costimulation; renal allograft; renal tubular cells; Th17

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DONOR SELECTION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH17 CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD40; APOPTOSIS; DENDRITIC CELLS; EPITHELIUM; KIDNEY; KIDNEY TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; TH17 CELLS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876483167     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12070     Document Type: Article

References (36)

1. Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D,. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
3. Larsen CP, Elwood ET, Alexander DZ, et al,. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
4. Kirk AD, Harlan DM, Armstrong NN, et al,. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A. 1997; 94: 8789.
5. Markees TG, Phillips NE, Noelle RJ, et al,. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64: 329.
6. Rossini AA, Parker DC, Phillips NE, et al,. Induction of immunological tolerance to islet allografts. Cell Transplant 1996; 5: 49.
7. Wekerle T, Sayegh MH, Ito H, et al,. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 1999; 68: 1348.
8. Takeuchi Y, Ito H, Kurtz J, Wekerle T, Ho L, Sykes M,. Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. Am J Transplant 2004; 4: 31.
9. Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M,. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation. Eur J Immunol 2005; 35: 2679.
10. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB,. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114.
11. Knechtle SJ, Hamawy MM, Hu H, Fechner JH Jr, Cho CS,. Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation. Immunol Rev 2001; 183: 205.
12. Koyama I, Kawai T, Andrews D, et al,. Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation 2004; 77: 460.
13. Badell IR, Thompson PW, Turner AP, et al,. Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates. Am J Transplant 2012; 12: 126.
14. Page A, Srinivasan S, Singh K, et al,. CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant 2012; 12: 115.
15. Cornell LD, Smith RN, Colvin RB,. Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol 2008; 3: 189.
16. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE,. MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990; 37: 783.
17. Waeckerle-Men Y, Starke A, Wahl PR, Wuthrich RP,. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation. Kidney Blood Press Res 2007; 30: 421.
18. Benichou G, Valujskikh A, Heeger PS,. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352.
19. Heidt S, Segundo DS, Chadha R, Wood KJ,. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010; 15: 456.
20. Ouyang W, Kolls JK, Zheng Y,. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454.
21. Crome SQ, Wang AY, Levings MK,. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2009; 159: 109.
22. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY,. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002; 197: 322.
23. Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C,. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 2000; 11: 2044.
24. Tian Y, Chen J, Gaspert A, et al,. Kidney transplantation in mice using left and right kidney grafts. J Surg Res 2010; 163: e91.
25. Vielhauer V, Allam R, Lindenmeyer MT, et al,. Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines. Am J Pathol 2009; 175: 119.
26. Segerer S, Eitner F, Cui Y, Hudkins KL, Alpers CE,. Cellular injury associated with renal thrombotic microangiopathy in human immunodeficiency virus-infected macaques. J Am Soc Nephrol 2002; 13: 370.
27. Chen Y, Zhang J, Li J, et al,. Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron Exp Nephrol 2006; 102: e81.
28. Nguan CY, Du C,. Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection. Transplant Rev (Orlando) 2009; 23: 129.
29. Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, Kopf M,. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci U S A 2009; 106: 876.
30. Hu Y, Shen F, Crellin NK, Ouyang W,. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 2010; 1217: 60.
31. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al,. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133.
32. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK,. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008; 181: 3906.
33. Demmers MWHJ, Baan CC, Weimar W, Rowshani AT,. Activated Tubular Epithelial Cells produce Chemokines that attract TH1, but not TH17 cells. 15th Congress of the European Society for Organ Transplantation, Glasgow, Scotland, 2011.
34. Starke A, Lindenmeyer MT, Segerer S, et al,. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney Int 2010; 78: 38.
35. Dugger K, Lowder TW, Tucker TA, Schwiebert LM,. Epithelial cells as immune effector cells: the role of CD40. Semin Immunol 2009; 21: 289.
36. Kairaitis L, Wang Y, Zheng L, Tay YC, Harris DC,. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney Int 2003; 64: 1265.